Jansman, Frank G.A.; Postma, Maarten J.; Brouwers, … - In: PharmacoEconomics 25 (2007) 7, pp. 537-562
. Therefore, comparative costs and cost effectiveness are important for assessing the value of new treatment regimens. The … studies of cost effectiveness were found. Since raltitrexed and 5-FU/folinic acid have shown equal efficacy in terms of … survival, cost-effectiveness analysis is considered not to be applicable and cost-minimisation analysis may be sufficient. At …